Xmoor Pharma and Royal Free London NHS Foundation Trust have announced a strategic collaboration to create a seamless pathway ...

The Cognitive Function Test, developed by experts at the Food for the Brain Foundation, has already been taken by more than 200,000 people. The charity, the only one in the UK focussing primarily on ...

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending Amvuttra ...

Bayer has reported encouraging topline findings from its global phase 3 OCEANIC-STROKE study, evaluating the investigational ...

The approvals represent the first PD-1 inhibitor plus ADC regimens for this patient population. Treatment involves Keytruda or Keytruda Qlex with Padcev before surgery and continued after cystectomy.

The Academy of Medical Sciences and Wellcome have announced a new five-year agreement worth £27.3 million, reinforcing their ...

GSK and the Fleming Initiative have announced six new research programmes to combat antimicrobial resistance (AMR), backed by ...

The bells are ringing out for another spectacular Christmas edition of PharmaTimes. This year, we recline and reflect on a ...

The European Commission has approved Libtayo (cemiplimab) as the first and only immunotherapy for adult patients with ...

Cellbyte, a Munich-based AI-native platform helping pharmaceutical companies accelerate drug launches, has raised $2.75 ...

“As the first biosimilar to Simponi (golimumab) to gain approval in the European market, we are committed to expanding access ...

Mursla Bio has announced a new collaboration with a leading global pharmaceutical company to support biomarker-guided drug ...